MAIA
MAIA Biotechnology Inc.
NYSE MKT: MAIA · HEALTHCARE · BIOTECHNOLOGY
$1.30
+4.00% today
Updated 2026-04-29
Market cap
$75.23M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.70
Dividend yield
—
52W range
$1 – $3
Volume
0.9M
MAIA Biotechnology Inc. (MAIA) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $-1.57M | $-1.84M | $-4.12M | $-12.10M | $-13.07M | $-15.70M | $-18.84B |
| Capital expenditures | $2.00 | $0.00 | $0.00 | $0.00 | $4.00 | $0.00 | $0.00 |
| Depreciation | — | — | — | — | — | — | — |
| Stock-based comp | $4.14M | $3.89M | $2.72M | $2.32M | $3.09M | $1.91M | $2.63B |
| Free cash flow | $-1.57M | $-1.84M | $-4.12M | $-12.10M | $-13.07M | $-15.70M | $-18.84B |
| Investing cash flow | $187556.00 | — | — | — | — | — | — |
| Financing cash flow | $2.22M | $798055.00 | $14.03M | $12.48M | $9.27M | $18.18M | — |
| Dividends paid | — | $58212.00 | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — |